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Introduction
Central organ systems, including heart, brain, gut, and
kidney, are particularly sensitive to ischemia followed
by reperfusion (I/R). Renal I/R injury alone imposes a
significant burden on the healthcare system because it
not only restricts function and availability of donor
kidneys for transplantation, but is also a serious com-
plication of circulatory shock.
More specifically, inflammation is considered to be a
major cause of I/R-induced tissue injury, because ther-
apeutic strategies aimed at reducing inflammation
often ameliorate I/R injury (1). The local inflammato-
ry reaction that follows reperfusion involves cytokines
such as proinflammatory TNF- a , as well as recruit-
ment of neutrophils. In vitro studies imply certain roles
for the anoxia-induced release of chemokines and neu-
trophil-endothelium interactions (2, 3) in the induc-
tion of inflammation after I/R. Nevertheless, little is
known about the specific events that trigger this
inflammatory response in vivo.
In this study, we investigate whether another early
consequence of I/R, apoptotic cell death (4), con-
tributes to the inflammatory response in a murine
model of renal I/R. Our results challenge the paradigm
which states that apoptosis represents a physiological
mode of cell deletion allowing disposal of superfluous
cells with minimal tissue reaction, or even with active
restraining of inflammation (5). We show that exoge-
nous IGF-1 (a growth and survival factor) and the
active caspase inhibitor Z-Val-Ala-Asp(OMe)-CH2F
(ZVAD-fmk) attenuate reperfusion-induced inflam-
mation, most likely because of their ability to inhibit
apoptosis in vivo. These findings strongly suggest that
apoptotic cell death, either directly or indirectly, sig-
nificantly contributes to I/R-induced inflammation, as
well as to the consequent tissue damage, and may pro-
vide new therapeutic means to treat I/R injury.
Methods
Antibodies and reagents. Anti-murine neutrophil mAb
Gr-1 was obtained from PharMingen (San Diego, Cal-
ifornia, USA); peroxidase-conjugated goat anti-rat and
goat anti-rabbit IgGs were obtained from The Jackson
Laboratory (Bar Harbor, Maine, USA); peroxidase-con-
jugated sheep anti-digoxigenin, digoxigenin 11-dUTP,
and terminal deoxynucleotidyl transferase (TdT) were
obtained from Boehringer Mannheim GmbH
(Mannheim, Germany); peroxidase-conjugated rabbit
anti-sheep IgG was obtained from DAKO A/S
(Glostrup, Denmark); the rabbit antiserum SA 2846
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sidered to be the most important cause of tissue injury in organs subjected to ischemia. The mecha-
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were administered after onset of apoptosis, these protective effects were completely abrogated. The
presence of apoptosis was directly correlated with posttranslational processing of the endothelial
monocyte-activating polypeptide II (EMAP-II), which may explain apoptosis-induced influx and
sequestration of leukocytes in the reperfused kidney. These results strongly suggest that apoptosis is
a crucial event that can initiate reperfusion-induced inflammation and subsequent tissue injury. The
newly described pathophysiological insights provide important opportunities to effectively prevent
clinical manifestations of reperfusion injury in the kidney, and potentially in other organs.
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was generated (Eurogentec, Seraing, Belgium) against
human recombinant mature endothelial monocyte-
activating polypeptide II (EMAP-II) (23 kDa) and rec-
ognized murine EMAP-II; Taq polymerase was
obtained from Perkin-Elmer Corp. (Norwalk, Con-
necticut, USA); LY294002 was obtained from Cal-
biochem-Novabiochem Corp. (San Diego, California,
USA); recombinant human IGF-1 was kindly provided
by H.P. Guler (Chiron Corp., Emeryville, California,
USA); ZVAD-fmk and ZFA-fmk were obtained from
Enzyme Systems Products Inc. (Livermore, California,
USA); Ac-YVAD-amc and Ac-DEVD-amc were
obtained from the Peptide Institute (Osaka, Japan). All
other reagents were purchased from Sigma Chemical
Co. (St. Louis, Missouri, USA).
Renal ischemia-reperfusion injury model. Male Swiss
mice weighing 20–25 g were obtained from Charles
River Breeding Laboratories (Heidelberg, Germany)
and were housed individually in standard laboratory
cages, with ad libitum access to food and water. The
studies were approved by the Institutional Animal
Care Committee of the University of Maastricht. At
the start of the experiments, mice were anesthetized
with sodium pentobarbital (50 mg/kg, intraperi-
toneally). A rectal probe (Cole-Parmer Instrument Co.,
Vernon Hills, Illinois, USA) to monitor body tempera-
ture was inserted, and body temperature was main-
tained at 39°C by a heating lamp until animals recov-
ered from anesthesia. Ischemia was induced by
clamping the left renal pedicle for 45 minutes using a
nontraumatic vascular clamp through a midline
abdominal incision. After clamp removal, the left kid-
ney was inspected for restoration of blood flow. Next,
the contralateral kidney was removed and stored for
further analysis. The abdomen was closed in 2 layers,
and 0.25% bupivacaine was applied topically for post-
operative pain management. Finally, to maintain fluid
balance and volume status, mice were supplemented
with 1 mL prewarmed (37°C) PBS subcutaneously.
The animals were sacrificed at different time points,
ranging from just before reperfusion through 24
hours after reperfusion. At the time of sacrifice, blood
was collected by orbital puncture, and the left kidney
was harvested for further analysis.
At the time of reperfusion, mice were administered
100 m g recombinant human IGF-1 subcutaneously (n
= 10), 30 m g ZVAD-fmk in 1% DMSO intraperitoneally
(n = 10), or 20 m g recombinant human EGF dissolved
in 0.3 mL PBS subcutaneously (n = 10). In separate
groups, 15 m g LY294002 in 0.3 mL PBS containing 1%
DMSO was administered intraperitoneally with (n =
10) or without (n = 10) IGF-1 treatment. Also in sepa-
rate groups, IGF-1 (n = 10) or ZVAD-fmk (n = 10) were
administered under similar conditions except after 2
hours of reperfusion. When compared with PBS treat-
ment, neither the solvent DMSO nor treatment with 30
m g Z-Phe-Ala-Ch2F (ZFA-fmk) in 1% DMSO (as a neg-
ative control for the caspase-inhibiting properties of
ZVAD-fmk) affected the outcome of performed exper-
iments (data not shown). Therefore, the control group
was treated subcutaneously with a vehicle consisting of
0.3 mL PBS (n = 12). A sham-operated group (n = 12)
was subjected to the same surgical procedure without
clamping the renal pedicle, and then was treated with
PBS and sacrificed at corresponding time points. The
dosages selected were based on pilot experiments with
respect to ZVAD-fmk and LY294002 (data not shown)
and on studies in which IGF-1 or EGF was found to
attenuate renal reperfusion injury (6).
Assays for myeloperoxidase and blood urea nitrogen. To
quantify the extent of renal neutrophil accumulation,
renal myeloperoxidase (MPO) content was determined.
Snap-frozen samples were thawed, homogenized for 30
seconds using a tissue homogenizer (T25B; IKA-Werke
GmbH, Staufen, Germany) at 20,000 g in 0.5% hexade-
cyltrimethylammonium bromide dissolved in 50 mM
PBS (pH 6.0), and then made up to concentrations of
0.17 g renal tissue/mL. After a 2-hour heat incubation in
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Figure 1
Representative light micrographs
showing evident in situ detection of
DNA nick ends by TUNEL histology
(a–c). The tubular epithelial cells of
the outer medulla from biopsies
obtained after 2 hours of reperfusion
showed positive staining (a), in con-
trast to kidneys obtained from sham-
operated mice (b) ( · 250). The presence of apoptotic bodies could
be detected extracellularly and extruded into the tubular lumen after
2 hours of reperfusion (c) ( · 1,000). Toluidine blue stains of 1-m m
sections, obtained from kidneys that were fixed in situ after 3 hours
of reperfusion and subsequently embedded in plastic (d and e),
revealed the presence of dense condensation of nuclear chromatin
and nuclear fragmentation in apoptotic tubular epithelial cells
(arrow) in the outer medulla (d), whereas morphological attributes
of tubular epithelial cell apoptosis were generally absent in sham-
operated mice (e) ( · 1,000).
a 60°C water bath to verify MPO heat resistance, sam-
ples were frozen and thawed to release cellular MPO.
Next, samples were spun at 11,000 g for 5 minutes, and
supernatants were then collected. Enzymatic detection
of MPO was performed in a 96-well plate (Corning-
Costar Corp., Cambridge, Massachusetts, USA). Assay
mixtures consisted of 40 m L H2O2 (final concentration:
0.3 mM) in 80 mM PBS (pH 5.4) and 40 m L in 0.5% hexa-
decyltrimethylammonium bromide in 50 mM PBS (pH
6.0) containing diluted sample. The reaction was initiat-
ed by addition of 20 m L tetramethylbenzidine (final con-
centration: 1.6 mM) in DMSO and stopped after 15 min-
utes by the addition of 50 m L/well of 1 M H2SO4.
Subsequently, OD was determined at 450 nm. All sam-
ples were assayed in triplicate. MPO activity was calcu-
lated per milligram of renal tissue by comparing OD of
sample wells with a titration curve of horseradish perox-
idase. The obtained relative MPO activities were stan-
dardized with respect to wet/dry ratios of the assayed
renal tissue. The activities are presented relative to the
amount of MPO present in the contralateral kidney,
which was harvested immediately after reperfusion and
normalized with respect to the MPO increase at day 1 in
PBS-treated mice subjected to I/R. Blood urea nitrogen
(BUN) content was measured in serum obtained by
orbital puncture at the time of sacrifice using a BUN
Unimate 5 kit in a Cobas Fara autoanalyzer (Hoffmann-
La Roche Ltd., Basel, Switzerland).
Apoptosis assays. Histological aspects of apoptosis
were studied by standard TdT-mediated dUTP nick
end labeling (TUNEL histology). To this end, 8- m m
frozen sections were fixed for 30 minutes in 4%
buffered formaldehyde, washed in PBS, pretreated for
10 minutes with PBS containing 0.6% H2O2, and then
washed again. DNA fragments were elongated and
labeled with TdT and digoxigenin 11-dUTP. Subse-
quently, sections were treated with sheep anti-digoxi-
genin antibodies and washed. Finally, peroxidase-
labeled rabbit anti-sheep antibodies, preincubated for
30 minutes in 10% murine serum, were applied and,
after washing, developed with diaminobenzidine sub-
strate. Sections that were pretreated with DNase 1 to
nick all DNA served as positive controls.
To quantify renal caspase activity, fluorogenic sub-
strates were used with predominant caspase-1– and cas-
pase-3–like affinities. Samples were homogenized,
snap-frozen, and then stored at –70°C in a buffer con-
taining 200 mM NaCl, 10 mM Tris-HCl (pH 7.0), 5 mM
EDTA, 10% glycerol, 1 mM PMSF, 0.1 m M aprotinin,
1.0 m M leupeptin, and 5 mM oxidized glutathione.
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Figure 2
Renal caspase-like activities were determined kinetically in homogenates of tissue obtained after 24 hours (a and c) and 2 hours (b and d)
of renal reperfusion in a fluorogenic substrate assay in which Ac-YVAD-amc (caspase-1–like) (a and b) or Ac-DEVD-amc (caspase-3–like) 
(c and d) served as substrates. Note that these data may represent a more generalized form of caspase activation, as outlined in the main
text. Data are expressed as the increase in fluorescence as a function of time, normalized against data obtained from the sham-operated
group. The groups that indicate t = 2 on the x-axis received the indicated treatment after 2 hours of reperfusion. All other groups were treat-
ed at the time of reperfusion. *P < 0.05, **P < 0.01 vs. control-treated animals. #P < 0.05, ##P < 0.01 vs. contralateral control kidney. The
data shown are mean – SEM.
Renal lysates (containing 40 m g total protein) were
incubated with 50 m M of the fluorogenic substrates Ac-
YVAD-amc (caspase-1–like) or Ac-DEVD-amc (caspase-
3–like) in a cell-free system buffer containing 10 mM
HEPES (pH 7.4), 220 mM mannitol, 68 mM sucrose, 2
mM NaCl, 2.5 mM KH2PO4, 0.5 mM EGTA, 2 mM
MgCl2, 5 mM pyruvate, 0.1 mM PMSF, and 1 mM DTT.
The release of fluorescent 7-amino-4-methylcoumarin
was measured for 1 hour at 2-minute intervals by spec-
trofluorometry (Cytofluor; PerSeptive Biosystems,
Framingham, Massachusetts, USA). Data are expressed
as the increase in fluorescence as a function of time,
and then normalized against the data obtained from
the sham-operated group.
The presence of internucleosomal DNA cleavage in
kidneys was investigated with a commercially available
ligase-mediated PCR (LM-PCR) assay kit (Apoalert;
CLONTECH Laboratories Inc., Palo Alto, California,
USA), enabling semiquantitative measurement of the
extent of apoptosis. In brief, DNA was isolated from tis-
sue samples (frozen previously at –70°C) using a com-
mercially available DNA purification kit (Wizard;
Promega Corp., Madison, Wisconsin, USA) according
to the manufacturer’s instructions. DNA purity and
concentration were determined by electrophoresis
through a 0.8% agarose gel containing ethidium bro-
mide, followed by observation under ultraviolet illu-
mination, as well as by measuring absorbance at
260/280 nm. Dephosphorylated adaptors were ligated
to 5 ¢ phosphorylated blunt ends with T4 DNA ligase
(during 16 hours at 16°C); they then served as primers
in LM-PCR under the following conditions: hot start
(72°C for 8 minutes, Taq polymerase added after 3 min-
utes), 25 cycles (94°C for 15 seconds, and 72°C for 180
seconds), and postcycling (72°C for 15 minutes). To
confirm that equal amounts of DNA were used for
PCR, an internal control that consisted of DNA ampli-
fication with En-2 primer pairs was performed. Ampli-
fied DNA was subjected to gel electrophoresis on a 1.2%
agarose gel containing ethidium bromide.
Histology. Histological aspects of apoptosis were
studied to verify that I/R also induced morphologi-
cal characteristics of apoptosis. Kidneys were fixed in
situ by perfusion with 2.5% glutaraldehyde in phos-
phate buffer through a left ventricular cardiac
catheter in anesthetized mice after 3 hours of reper-
fusion. After perfusion fixation, renal specimens con-
taining outer medulla segments were fixed in 2.5%
glutaraldehyde overnight. Next, segments were post-
fixed in 1% osmium tetroxide, dehydrated in graded
alcohols, and then embedded in Epon 812 plastic.
Finally, 1- m m sections were stained with toluidine
blue for light microscopic examination.
From animals in the different treatment groups,
specimens of harvested kidneys were immediately
frozen and stored at –70°C. Next, 5- m m sections were
stained for neutrophils with mAb Gr-1, using peroxi-
dase-labeled goat anti-rat IgG as the secondary detec-
tion mAb and 3-amino-9-ethylcarbazole as a chro-
mogen followed by a hematoxylin counterstain. To
block nonspecific peroxidase activity, sections were pre-
treated for 10 minutes with PBS containing 0.03%
H2O2. No significant staining was detected in slides
incubated with control mAb instead of the primary
detecting mAb.
Western blot analysis. Frozen samples of harvested kid-
neys were homogenized in a buffer containing 200 mM
NaCl, 10 mM Tris-HCl (pH 7.0), 5 mM EDTA, 10%
glycerol, 1 mM PMSF, and 0.1 m M aprotinin. After cen-
trifugation at 15,000 g, protein in the supernatants was
quantified by the Bradford method and boiled in
Laemmli buffer. Then, 35 m g of protein per lane was
electrophoresed in 15% SDS-PAGE. Proteins were
transferred to nitrocellulose membranes, which were
subsequently blocked with PBS/5% nonfat dry milk
and then incubated for 3 hours with EMAP-II anti-
serum (SA 2846; diluted 1:2,000 in PBS/0.1% Tween-
20). After washing, the membranes were incubated for
2 hours with peroxidase-labeled goat anti-rabbit IgG
(diluted 1:2,000 in PBS/0.1% Tween 20), washed, and
then developed by enhanced chemiluminescence.
Statistics. Data are expressed as the mean ± SEM,
and statistical analysis was performed by Student’s t
test. P values less than 0.05 were considered statisti-
cally significant.
Results
Renal I/R induces apoptosis and subsequent inflammation. To
determine the extent of apoptosis, and to exclude
necrosis or mechanisms independent from apoptosis
as main contributors to DNA fragmentation, different
techniques were used. Kidneys were investigated by
TUNEL histology to localize DNA fragmentation after
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Figure 3
The extent of renal apoptosis in different treatment groups is also
reflected by the presence of fragmented DNA (as a result of internu-
cleosomal DNA cleavage), amplified by LM-PCR and then viewed on
ethidium bromide–stained gel. M, molecular weight markers (range:
100–2,000 bp).
reperfusion. For morphological assessment of apopto-
sis, toluidine blue histology was performed using plas-
tic-embedded tissues. Also, caspase-like activities and
internucleosomal DNA cleavage were measured in
homogenates of kidneys obtained after reperfusion.
TUNEL-positive nuclei, restricted mainly to the tubu-
lar epithelial cells of the outer medulla, were identified
in biopsies obtained after as little as 2 hours of reper-
fusion (Figure 1, a and b). At this time point, TUNEL
histology revealed the extracellular presence of apop-
totic bodies, which were often extruded into the tubu-
lar lumen (Figure 1c). In a separate group of mice, sac-
rificed after 3 hours of reperfusion, toluidine
blue–stained 1- m m sections showed dense condensa-
tion of nuclear chromatin and nuclear fragmentation
in apoptotic tubular epithelial cells (Figure 1, d and e).
In addition, increased renal caspase-1– and caspase-
3–like activities (Figure 2, b and d), as well as apparent
internucleosomal DNA cleavage (Figure 3), were
observed after 2 hours of reperfusion.
As documented previously (4), after 1 day of reperfu-
sion the number of tubular epithelial cells containing
TUNEL-positive nuclei had increased, and TUNEL-
positive nuclei of infiltrating immune cells were
observed (data not shown). Also at this time, increased
renal caspase-1– (Figure 2a) and caspase-3–like (Figure
2c) activities were detected. Together with the observed
occurrence of internucleosomal DNA cleavage (Figure
3), these findings suggest the presence of ongoing renal
apoptosis starting as early as 2 hours after reperfusion.
IGF-1 abrogates early apoptosis, impaired renal function, and
I/R-induced inflammation. We first investigated the rela-
tion between I/R-induced apoptosis and inflammation
by using IGF-1, because pilot experiments revealed that
this agent prevented I/R-induced apoptosis in murine
kidneys. Administration of IGF-1 at the time of reper-
fusion — as opposed to administration of PBS — pre-
vented apoptosis, as indicated by a decreased number of
TUNEL-positive nuclei (data not shown), decreased cas-
pase-like activities (Figure 2), and the absence of appar-
ent internucleosomal DNA cleavage (Figure 3). These
data reveal the antiapoptotic potential of IGF-1 in an
early phase after renal ischemia.
Next, we studied whether abrogation of early apopto-
sis affects the later consequences of renal I/R. IGF-1
administration at the time of reperfusion prevented the
I/R-induced impairment of renal function, as reflected
by increased BUN content at day 1 (Figure 4). Moreover,
IGF-1 treatment limited I/R-induced inflammation at
that time point by reducing the renal influx of neu-
trophils, as reflected by the presence of Gr-1–positive
cells (Figure 5, a and b) and the increased renal MPO
activity (Figure 5c). Taken together, these findings indi-
cate that exogenous IGF-1 prevents I/R-induced apop-
tosis, impairment of renal function, and inflammation.
Protection from I/R-induced apoptosis by IGF-1 is mediated
by phosphatidylinositol 3-kinase. Phosphatidylinositol 3-
kinase (PI 3-kinase), an important component of signal
transduction by insulin family receptors, has been
reported to mediate antiapoptotic signaling by IGF-1
in vitro (7). To investigate more closely the mechanisms
by which IGF-1 attenuates reperfusion-induced apop-
tosis and inflammation, we treated mice with a combi-
nation of IGF-1 and LY294002 (a selective PI 3-kinase
inhibitor) (8). In contrast to IGF-1 treatment, com-
bined administration of IGF-1 and LY294002 at the
time of reperfusion failed to prevent apoptosis. Ani-
mals treated with this combination exhibited an abro-
gation of IGF-1–induced inhibition of apoptosis,
resulting in increased numbers of TUNEL-positive
nuclei (data not shown), significant caspase-like activ-
ity (Figure 2), as well as apparent internucleosomal
DNA cleavage (Figure 3) at day 1 after I/R. Moreover, at
this time point, they exhibited decreased renal function
(Figure 4) and an increased renal neutrophil influx
(Figure 5c) when compared with IGF-1–treated ani-
mals. LY294002 treatment, compared with PBS treat-
ment, did not result in significant differences in any of
the parameters evaluated (Figures 2–5). These data
demonstrate that in vivo antiapoptotic signaling by
IGF-1 is mediated by the PI 3-kinase pathway.
Inflammation is dependent on antecedent apoptosis after
renal I/R. Besides antiapoptotic properties, IGF-1 has a
well-documented mitogenic potential that may con-
tribute to the repair and recovery of ischemically
injured renal tissue. To address the question whether
the mitogenic effects of IGF-1 were responsible for the
observed prevention of apoptosis and inflammation in
our model, mice were treated with EGF, a powerful
mitogen for renal epithelial cells. EGF administered at
the time of reperfusion failed to prevent reperfusion-
induced renal apoptosis, as reflected by increased num-
bers of TUNEL-positive nuclei (data not shown), sig-
nificant caspase-like activity (Figure 2), and apparent
internucleosomal DNA cleavage (Figure 3) at day 1.
Hence, the absence of any antiapoptotic effect excludes
the possibility that EGF, as opposed to IGF-1, func-
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Figure 4
Renal function in the different experimental groups as reflected by
BUN content. **P < 0.01, ***P < 0.001 vs. control-treated animals.
The data shown are mean – SEM.
tions as a survival factor in the model used. Moreover,
as opposed to IGF-1, EGF did not prevent I/R-induced
impaired renal function (Figure 4) or inflammation
(Figure 5c) at day 1.
To investigate whether the anti-inflammatory effect
of exogenous IGF-1 is a direct effect rather than a con-
sequence of the absence of apoptosis, mice were treated
with the tripeptide caspase inhibitor ZVAD-fmk at the
time of reperfusion, as well as after 2 hours of reperfu-
sion. At the later time point, the presence of renal apop-
tosis is evident (Figure 1), whereas an inflammatory
response, as defined by the present parameters, cannot
yet be distinguished (Figure 5c). In line with a recent
report on cardiac I/R (9), we show that ZVAD-fmk
administered at the time of reperfusion completely
abrogated renal apoptosis (Figures 2 and 3). In addition,
ZVAD-fmk administered at the time of reperfusion pre-
vented the impairment of  renal function (Figure 4) and
the development of the inflammatory response (Figure
5c) at day 1. In contrast, ZVAD-fmk administered after
2 hours of reperfusion not only failed to attenuate the
extent of the already initiated apoptotic response (Fig-
ures 2 and 3), but it also failed to attenuate subsequent
impairment of renal function (Figure 4) and the inflam-
matory response (Figure 5c). Similarly, at day 1, no
reversal of renal apoptosis could be detected in mice
that received IGF-1 after 2 hours of reperfusion (Figures
2 and 3); in addition, these animals exhibited signs of
inflammation (Figure 5c) and impaired renal function
(Figure 4), as seen in PBS-treated animals. These find-
ings indicate that development of inflammation is
dependent on antecedent apoptosis after I/R. Since
abrogation of apoptosis by IGF-1 or ZVAD-fmk limits
I/R-induced inflammation, apoptosis is a likely candi-
date for induction of inflammation in the model used.
Posttranslational processing of EMAP-II coincides with I/R-
induced apoptosis and is inhibited by IGF-1 and ZVAD-fmk.
The precursor form of EMAP-II can serve as a target
substrate for activated caspases (10). We used Western
blotting to investigate the effect of I/R on posttransla-
tional processing of EMAP-II. Figure 6 shows that I/R
results in enhanced cleavage of the 43-kDa EMAP-II
precursor as early as 2 hours of reperfusion. The active
23-kDa cleavage product remained detectable in kid-
neys subjected to 24 hours of reperfusion. Hence, the
formation of functional EMAP-II coincides with the
manifestation of apoptosis after renal I/R. EMAP-II
activation was clearly inhibited in kidneys obtained
from sham-operated animals or from mice treated with
ZVAD-fmk at the time of reperfusion, after 2 hours
(data not shown) or 24 hours (Figure 6) of reperfusion.
At these time points, animals that were treated with
IGF-1 at the time of reperfusion exhibited only low-
intensity 23-kDa bands (Figure 6). Digital image analy-
sis of activated EMAP-II protein band intensities of the
representative EMAP-II Western blot (Figure 6) reveals
that the intensity of the 23-kDa band after IGF-1 treat-
ment is approximately 5% of the 23-kDa band intensi-
ty 24 hours after PBS treatment. These findings are in
line with the other parameters measured in IGF-
1–treated animals. As shown in Figure 6, the formation
of 23-kDa EMAP-II also resulted in formation of bands
representing a molecular mass between 23 and 43 kDa,
which has been suggested to be the result of interme-
diate cleavage product formation (10). These results
demonstrate that renal I/R induces EMAP-II activation.
Both IGF-1 and the caspase inhibitor ZVAD-fmk
strongly reduce EMAP-II activation, which may explain
the observed ability of these agents to inhibit the apop-
tosis-induced inflammatory response after renal I/R.
Discussion
We hypothesized that apoptosis after I/R constitutes a
potential trigger of inflammation, and we studied this
possibility by using inhibitors of the apoptotic response
in a murine model of renal I/R. Evidence for the early
involvement of apoptosis is provided by the presence of
DNA fragmentation, morphological features character-
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Figure 5
Representative light micrographs (a and b) showing infiltrating neutrophils in areas with impaired renal morphological integrity in biop-
sies obtained from mice subjected to renal I/R after 1 day of reperfusion (a). Neutrophils were stained with the anti-murine neutrophil
mAb Gr-1. Neither loss of morphological integrity nor infiltrating neutrophils were observed in kidneys obtained from sham-operated mice
(b) ( · 200). Neutrophil influx was assessed quantitatively by determination of MPO increase at 2 hours and 1 day of reperfusion (c). Val-
ues are presented relative to the amount of MPO present in the contralateral kidney harvested immediately after reperfusion, and then
normalized with respect to the MPO increase at day 1 in PBS-treated mice subjected to I/R. *P < 0.05 vs. control-treated animals. The data
shown are mean – SEM.
istic for apoptosis, as well as increased caspase-1– and cas-
pase-3–like activities in kidneys after 2 hours of reperfu-
sion. These findings are in line with various in vivo and
in vitro reports showing that renal apoptosis after
ischemia is induced by hypoxia (11) and ATP depletion
(12). In addition, hydrolyzation of the plasma membrane
component sphingosine, and consequent liberation of
ceramide, has been reported to initiate apoptosis after as
little as 30 minutes of renal reperfusion (13). Further-
more, during I/R-induced inflammation at day 1, upreg-
ulated Fas (capable of inducing apoptosis independent
of ceramide signaling) (4), TNF-a (14), and P53 (15) have
been associated with I/R-induced apoptosis. In contrast,
our in vivo findings clearly differ from data presented by
Ueda et al. (16), who reported that anoxia followed by
reoxygenation of isolated rat proximal tubules in vitro
may occur without morphological aspects of apoptosis.
The present findings show that mice treated with a
single dose of IGF-1 at the time of reperfusion exhibit-
ed abrogation of apoptosis, as demonstrated by
decreased numbers of TUNEL-positive nuclei,
decreased renal caspase-like activities, and the absence
of apparent internucleosomal DNA cleavage. These
results confirm that IGF-1 is a potent inhibitor of reper-
fusion-induced apoptosis. In addition, ZVAD-fmk, a
broad spectrum inhibitor of activated caspases, abro-
gated I/R-induced apoptosis, whereas ZFA-fmk, a
homologous peptide lacking the caspase-inhibiting
properties of ZVAD-fmk, failed to prevent apoptosis.
Hence, inhibition of apoptosis prevented the loss of kid-
ney function and the development of an inflammatory
response. In contrast, administration of antiapoptotic
IGF-1 or ZVAD-fmk after 2 hours of reperfusion (after
the onset of apoptosis) failed to prevent loss of kidney
function and inflammation. Few studies have addressed
the potential of IGF-1 in ischemia-induced apoptosis
(17, 18). The latter report (18) assumed a distinct “anti-
neutrophil property” apart from the antiapoptotic
effects of IGF-1. In contrast, our findings clearly define
apoptosis as an event arising proximal to the onset of
I/R-induced inflammation.
We investigated whether mechanisms other than the
inhibition of apoptosis contributed to the anti-inflam-
matory and renal function–improving effects of IGF-1
and ZVAD-fmk. Caspase-1– and caspase-3–like activities
during I/R-induced apoptosis were significantly pre-
vented by IGF-1 or ZVAD-fmk administered at the time
of reperfusion. Whereas caspase-3 activation reflects
many forms of apoptosis (19), a functional role for cas-
pase-1 during apoptosis appears to be restricted to cell
death induced by specific agents such as FasL (20) and
granzyme B (21). Caspase-1, also referred to as IL-1–con-
verting enzyme (ICE), is involved in, but not essential to,
the maturation of IL-1 and IL-18 (22, 23). Therefore,
activated caspase-1–induced release of IL-1 and/or IL-18
may contribute to the inflammatory response after I/R
(23). However, inhibition of endogenous IL-1 (ref. 24 and
our own unpublished observations) and IL-18 (25) only
minimally decreased renal influx of neutrophils and loss
of kidney function after 1 day of reperfusion when com-
pared with administration of IGF-1 or ZVAD-fmk (data
not shown). Finally, it has to be taken into account that
the measured renal caspase-like activities are likely to
represent a more generalized form of caspase activation,
because enzymatic activities of caspase-1 and caspase-3
on Ac-YVAD-amc and Ac-DEVD-amc have been shown
to be not fully specific (26).
The anabolic effect attributed to IGF-1, putatively
leading to enhanced tissue repair, may add to the ther-
apeutic effect of IGF-1 (6). Moreover, IGF-1–induced
renal nitric oxide (NO) can improve kidney function by
directly enhancing renal circulation (27), as well as by
contributing to limitation of apoptosis through inhibi-
tion of caspases (28). However, direct anti-inflammato-
ry effects of IGF-1 have not been reported previously.
The present findings show that neither treatment with
EGF, a renotropic growth factor with anabolic effects
similar to IGF-1 (29), nor treatment with IGF-1 or
ZVAD-fmk after 2 hours of reperfusion attenuated the
loss of kidney function or inflammation.
Similar to in vitro observations (7, 30), we further
showed, by coadministrating the PI 3-kinase inhibitor
LY294002, that PI 3-kinase constitutes an essential
component of IGF-1 receptor–mediated, antiapoptotic
signaling in vivo. Taken together, these results demon-
strate that the anti-inflammatory effects of IGF-1 and
ZVAD-fmk are distinctively mediated by antiapoptotic
signaling rather than by inhibition of IL-1 and/or IL-18
maturation, anabolic stimulation, or NO-induced
enhanced kidney function. Nevertheless, despite the
lack of an apparent functional role for activated cas-
pase-1 in our model, our findings do not definitely rule
out the possibility that apoptosis and inflammation are
2 largely independent processes that share thus far
unknown upstream molecular mechanisms.
The present findings demonstrate that inhibition of
apoptosis after renal I/R prevents subsequent inflam-
mation. This apparently shows apoptosis to be critical
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Figure 6
Posttranslational processing of the EMAP-II protein is induced in par-
allel with apoptosis after as little as 2 hours of reperfusion. Western
blots were performed with protein isolated from kidneys in mice that
were sacrificed after different periods of reperfusion. Incubation with
the EMAP-II antiserum SA 2846 revealed constitutive expression of
inactive pro–EMAP-II, which resulted in a 43-kDa band. After 2 hours
of reperfusion, the presence of 23-kDa mature EMAP-II was
observed, which was even more apparent after 24 hours of reperfu-
sion. Antiapoptotic treatment at the time of reperfusion with IGF-1
or ZVAD-fmk evidently inhibited I/R-induced EMAP-II maturation.
for the induction of inflammation in the present model.
Our results also demonstrate that I/R induces activation
of EMAP-II. Inactive pro–EMAP-II may serve as a target
substrate for activated caspases (10), which we presently
show to be upregulated as a consequence of I/R. The evi-
dent formation of mature EMAP-II coinciding with elab-
oration of I/R-induced apoptosis, as well as the observed
decrease in EMAP-II activation after IGF-1 or ZVAD-fmk
treatment, is in line with a recent report of Knies et al.
(10). This study showed that the release of mature
EMAP-II is directly linked to apoptosis and can be abro-
gated in vitro by caspase inhibition. Mature EMAP-II is
a potent chemokine that stimulates migration of poly-
morphonuclear neutrophils and monocytes in vivo,
release of tissue factor on endothelial cells (31), and
TNF-a from monocytes (32). Its peptide sequence
exhibits strong regional homology with other proin-
flammatory mediators such as human von Willebrand
factor antigen II (33) and IL-8 (34). Furthermore, it was
recently demonstrated that mediators of apoptosis can
cleave aminoacyl-tRNA synthetase, which subsequently
leads to release of proinflammatory cleavage products
similar to EMAP-II, like the NH2-terminal catalytic
domain of tyrosyl tRNA synthetase (35).
The present data suggest that EMAP-II maturation,
as a consequence of I/R-induced apoptosis, con-
tributes to recruitment of inflammatory cells to the
reperfused kidney. However, more studies are needed
to determine the functional role of EMAP-II in I/R and
to elucidate other mechanisms by which apoptosis
induces an inflammatory response. The absence of
sufficient phagocytosis of apoptotic cells has been
associated with further degeneration, and ultimately
necrosis, of apoptotic cells, a process termed second-
ary necrosis (36, 37). This secondary necrosis has been
suggested to occur when the extent of necrosis over-
whelms the phagocytic capacity of the tissue (38), and
it appears to be another important link between apop-
tosis and inflammation. It is tempting to conclude
that phagocytosis cannot deal sufficiently with sudden
widespread apoptosis within an organ subjected to
prolonged ischemia, which ultimately leads to sec-
ondary necrosis and inflammation.
Many documented attempts to directly reduce the I/R-
induced inflammatory response in various models have
unmasked inflammation as a significant cause of subse-
quent tissue injury and dysfunction (1, 14). The present
studies indicate that early apoptosis is a crucial event in
the process that initiates inflammation and subsequent
tissue injury. This is because abrogation of early I/R-
induced apoptosis prevents the development of inflam-
mation and organ dysfunction. This concept of apopto-
sis-induced inflammation after I/R puts forth new,
important opportunities to effectively prevent clinical
manifestations of reperfusion injury. Such therapies may
include, prevention of complications arising from the use
of ischemically damaged donor organs, cardiopulmonary
bypass surgery, aortic cross-clamping, and circulatory
shock. Agents such as IGF-1 (which can be safely admin-
istered to humans) and ZVAD-fmk, as well as new anti-
apoptotic substances currently under investigation, may
provide new therapeutic means to treat these conditions.
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